Medi-Weightloss Clinics

What Medi-Weightloss Clinics does

Medi-Weightloss Clinics is a physician-supervised medical weight loss franchise founded in 2005 by Edward Kaloust and headquartered in Tampa, Florida. The company operates through a franchise model with 137 independently owned and operated clinic locations across the United States (per the corporate website), supported by a corporate headcount that, combined with franchise staff, totals over 750 employees including physicians, nurse practitioners, and medical assistants. Its core offering is the Medi-Weightloss Program, an evidence-based clinical protocol that combines physician consultations, lab work, body composition analysis, personalized nutrition plans, and ongoing medical supervision, with documented outcomes of an average 29 pounds of weight loss in 13 weeks per patient and a cumulative 10 million pounds lost across the patient base.

The product portfolio centers on the core program with a stack of add-on modules: FDA-approved and compounded GLP-1 medications (Wegovy, Zepbound, compounded Semaglutide and Tirzepatide), traditional appetite suppressants (Phentermine, Phendimetrazine), hormone optimization, IV therapy, vitamin and nutrition injections, an adolescent program, the MediLiving long-term maintenance program, and corporate wellness offerings. The underlying technology stack is operationally focused — a standard Electronic Medical Records system for clinical documentation, a patient portal for account access, and an e-commerce storefront for supplements — with no proprietary AI/ML capabilities disclosed. The franchise model, trademarked brand (MEDI-WEIGHTLOSS), and standardized clinical protocols are the principal sources of operational leverage.

The company monetizes through a combination of franchise fees and royalties from independently owned clinic operators, recurring monthly patient program subscriptions, transactional product sales through the e-commerce shop and clinic-based supplement sales, and subscription-based corporate wellness contracts with employers. Many franchise locations accept major insurance carriers and HSA/FSA accounts, broadening patient access. The company is privately held, has not disclosed any institutional funding rounds, and reports no parent company or subsidiary structure; ownership remains with founder Edward Kaloust alongside CEO Brian Petranick, COO Charolette Obringer, and a Tampa-based executive team. Recent strategic activity has focused on geographic expansion into Oregon, broadening the medication portfolio around GLP-1 demand, and extending the product line into maintenance and B2B segments.

Name

Medi-Weightloss Clinics

Legal name

Medi-Weightloss Franchising USA, LLC

Website

https://mediweightloss.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

251–500 employees

Short description

Medi-Weightloss Clinics is a Tampa-based physician-supervised medical weight loss franchise founded in 2005, operating 137 clinics nationwide that deliver personalized programs, GLP-1 medications, and ongoing clinical supervision to individual consumers.

Ownership category

akta.pro rank

Product category

Medical Weight Loss Services

NAICS

Diet and Weight Reducing Centers (812191), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

akta.pro secondary industries

Corporate/Workplace Nutrition & Weight Management Programs (HSADAFAO), Weight Management & Metabolic Supplements (CRADAGAG)

Keywords

• Medical weight loss
• Physician-supervised weight loss
• GLP-1 medications
• Weight loss clinic
• Medical weight management

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Franchise Fees and Licensing: Medi-Weightloss generates revenue through franchise ownership fees, with independently owned and operated clinics paying for the right to use the Medi-Weightloss brand, protocols, and operational support.
2. Patient Program Fees: Individual patients pay for medical weight loss programs which include physician consultations, lab work, body composition analysis, personalized plans, and ongoing medical supervision. Many locations accept insurance and HSA/FSA accounts.
3. Products and Supplements: Revenue generated from sales of supplements, vitamin injections, IV therapy products, and related wellness products through the clinic shop.
4. Corporate Wellness Programs: B2B corporate wellness offerings providing employee weight loss and wellness programs to employer partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Medi-Weightloss operates a physician-supervised medical weight loss franchise with 137+ clinic locations across the United States. The company provides personalized weight loss programs including physician consultations, lab work, body composition analysis, prescription medications (GLP-1 receptor agonists such as Semaglutide and Tirzepatide, plus Phentermine/Phendimetrazine), and ongoing medical supervision. Revenue is generated through patient program fees, franchise licensing, and product/supplement sales.

Product overview

Medi-Weightloss is a physician-supervised medical weight loss platform operating on a franchise model with over 137 locations nationwide. The core offering is the Medi-Weightloss Program, an evidence-based clinical weight loss solution supplemented by multiple add-on modules including GLP-1 medications (Semaglutide, Tirzepatide), appetite suppressants (Phentermine/Phendimetrazine), Hormone Optimization, IV Therapy, Vitamin & Nutrition Injections, an Adolescent Program, Corporate Wellness services, and the MediLiving maintenance program. The portfolio integrates pharmaceutical interventions with lifestyle support to address obesity as a medical condition requiring individualized treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• Medi-Weightloss Program

Quantifiable outcome

• Average weight loss of 29 pounds in 13 weeks
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators5 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Ideal Protein: Physician-supervised medical weight loss protocol with a clinic/coach network and packaged food component. Highly comparable to Medi-Weightloss in target patient, supervision model, and clinic-based delivery.
• Lindora: Long-standing medical weight loss clinic chain offering physician-supervised programs, medications, and lifestyle coaching across multiple U.S. locations. Directly comparable in clinical model and service mix.
• Profile by Sanford: Sanford Health-affiliated medical weight loss program with in-person coaching and clinical oversight. Closely overlaps Medi-Weightloss on physician-supervised, behavior-plus-medication approach.
• Noom (Noom Med): Digital weight management platform that has expanded into clinician-supervised GLP-1 prescribing via Noom Med. Directly comparable as a medically-supervised weight management competitor targeting the same patient demand.
• Jenny Craig: Legacy branded weight loss program historically delivered through company-owned and franchise centers with food + coaching. Comparable clinic-format competitor, though operating at smaller scale than Medi-Weightloss today.

Emerging players

• Hims & Hers Health: Direct-to-consumer telehealth platform that has aggressively pushed into weight loss and GLP-1 access. Comparable as a competing channel for medically supervised GLP-1 prescriptions, especially for younger, digital-first patients.
• Ro: Telehealth platform with a dedicated weight loss vertical offering GLP-1s and clinician consultations. Comparable as a digitally native, medically supervised alternative competing for the same GLP-1 patient cohort.
• Sequence (now WeightWatchers Clinic): Telehealth weight management service acquired by WW that prescribes GLP-1s with clinician oversight. Comparable as a digitally delivered, medically supervised offering targeting the same patient demand.

Broad incumbents

• WeightWatchers (WW): Established weight management brand with national recognition that has expanded into clinician-supported GLP-1 pathways. Comparable as a broad incumbent competing for the same end patient across both behavioral and medical modalities.
• Optavia / Medifast: Large multi-channel weight management company combining coaching, meal replacements, and increasingly clinical offerings. Comparable as a scaled, branded competitor in the broader weight loss category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/user/mediweightloss
• Facebookfacebook.com/1.877.MED.LOSS
• LinkedInlinkedin.com/company/medi-weightloss-clinics-franchise-hq
• Instagraminstagram.com/theonethatworks

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medi-Weightloss Clinics